KCI Usa, Inc.

KCI USA, Inc., doing business as Solventum Advanced Wound Care, manufactures and delivers negative pressure wound therapy systems, wound vacuum-assisted closure equipment, and advanced wound care supplies to federal healthcare agencies as a large for-profit prime contractor (100% of prime awards) with no small business set-aside designations. The company is a wholly-owned subsidiary of 3M Company headquartered in San Antonio, Texas, competing through full and open competition on proprietary wound care technologies across the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and National Institutes of Health.

Customer concentration is extreme and concentrated within the VA's decentralized Veterans Integrated Service Network structure. The top customer by potential value — Veterans Integrated Service Network 12 — accounts for $664.3 million across just 18 awards (85% of all combined potential value), an outlier reflecting a single large equipment lease arrangement. The top five customers by potential-value ranking collectively represent 91% of combined potential value. By award count, the customer distribution is more dispersed: VISN 15 leads with 337 awards valued at $3.1 million; VISN 22 follows with 190 awards at $15.2 million; and VISN 9 holds 157 awards at $10.4 million. The two rankings diverge sharply — VISN 12's massive dollars sit atop a small award count, while VISNs 15 and 2 generate volume (337 and 190 awards respectively) but smaller per-award values. Across all 40 distinct customer agencies, the Department of Veterans Affairs represents the overwhelming majority of the footprint.

KCI USA's vehicle position is anchored by a single dominant master contract: the $340 million Medical Equipment and Supplies Federal Supply Schedule (FSS-65-II-A), awarded June 2023 with performance through May 31, 2028, which generated 1,855 task orders valued at $110.8 million. The company also holds multiple single-award Blanket Purchase Agreements with individual Veterans Integrated Service Networks, ranging from $25,006 (VISN 15, December 2025) to $1.58 million (VISN 5, August 2025). Additionally, KCI USA maintains a $249 thousand BPA with Pacific Air Forces for wound vacuum therapy rentals through May 2027. These vehicles enable decentralized ordering of wound care products across federal healthcare facilities.

Activity has remained steady to declining over the past five years: 45 awards in 2022, 40 in 2023, 57 in 2024, 47 in 2025, and 20 recorded in 2026 (partial year). Twenty-six awards with ultimate completion dates in the next twenty-four months carry combined potential value of $10 million, representing modest recompete exposure relative to the vendor's portfolio scale, though the $664.3 million VISN 12 lease expiring June 28, 2031, sits beyond the twenty-four-month window.

SCI-reportable federal service contract activity is minimal, reflecting KCI USA's core business model as a product and equipment supplier rather than a services contractor. The SCI dataset captures only $1.2 million in invoiced revenue across FY2022–FY2025, concentrated in FY2024 with 0.3 FTEs. Government-paid hourly rates on reportable service work ranged from a 10th percentile of $854 per hour to a 90th percentile of $2,833.33 per hour, with a median around $1,285 per hour. Across SCI-reportable prime contracts, the company engaged zero subcontractor hours, delivering all work through direct staff.

KCI USA operates as a pure prime contractor with zero subcontractor engagement on its federal work. The vendor performs wound care equipment manufacturing, rental operations, and field support directly, with no identified teaming relationships or notable sub-awards. Three sub-awards on record were issued between March 2022 and September 2022 through Cardinal Health 200, LLC, for surgical instrument consumables — these represent KCI USA as supplier to a larger prime rather than KCI USA sourcing from subs.

The capability portfolio centers on proprietary negative pressure wound therapy technologies marketed under the Solventum Advanced Wound Care, ActiV.A.C., and V.A.C. ULTA brands. Representative prime awards span wound vacuum equipment rental (VISN 22, $1.96 million for ULTA therapy units with VeraFlow technology, July 2025); equipment lease agreements (VISN 21, $2.24 million for wound VAC medical equipment lease option year 2, July 2024); maintenance and repair services (VISN 12, $361.7 thousand for preventative maintenance on 31 V.A.C. Ultra units at Hines VA, September 2022); and consumable supplies such as wound dressings and kits. Work is performed across the continental United States, with administrative offices and place-of-performance centered in San Antonio, Texas. The Indian Health Service, Defense Health Agency, and NIH Clinical Center also issue direct orders under the FSS-65-II-A, with individual delivery orders ranging under $5,000 for express consumable orders to over $2.2 million for comprehensive therapy system leases.